Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development is a research paper published in Expert Opinion on Investigational Drugs (2020). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH/NINDS
Grant: Basic Research Fellowship “in Memory of Bruce an
NIH/NINDS
Grant: R01-EB022563
NIH/NINDS
Grant: and R01-NS096756
NIH/NIBIB
Grant: 1R21NS107894
NIH/NIBIB
Grant: R01-NS076991
NIH/NIBIB
Grant: R01-NS096756
NIH/NIBIB
Grant: R01-NS105556
NIH/NIBIB
Grant: R37-NS094804
MeSH Terms
Keywords